<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It is not known whether the association between increased plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (<z:chebi fb="0" ids="17230">Hcy</z:chebi>) associated with <z:chebi fb="15" ids="39026">LDL</z:chebi> modification and propensity for <z:chebi fb="15" ids="39026">LDL</z:chebi> uptake by macrophages in <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> patients holds true in vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) </plain></SENT>
<SENT sid="1" pm="."><plain>Plasma from 83 subjects diagnosed with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD), VaD, mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> (MCI) and from controls was analysed to examine (1) whether <z:chebi fb="15" ids="39026">LDL</z:chebi> isolated from the plasma of VaD is biochemically and functionally distinct from that isolated from AD, MCI or controls; and (2) whether such biomarkers of <z:chebi fb="15" ids="39026">LDL</z:chebi> phenotype are related to plasma <z:chebi fb="3" ids="37445">folate</z:chebi> levels, <z:chebi fb="0" ids="17230">Hcy</z:chebi> levels and/or to disease severity </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="3" ids="37445">Folate</z:chebi> and <z:chebi fb="14" ids="27306">vitamin B6</z:chebi> levels were significantly lower in VaD subjects than in controls </plain></SENT>
<SENT sid="3" pm="."><plain>VaD-<z:chebi fb="15" ids="39026">LDL</z:chebi> showed increased protein <z:chebi fb="1" ids="23019">carbonyl</z:chebi> content (p &lt; 0.05) and was more susceptible to scavenging by macrophages (p &lt; 0.05) than AD- or control-<z:chebi fb="15" ids="39026">LDL</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Patients from the VaD cohort were more prevalent in the lowest tertile for <z:chebi fb="17" ids="39025">HDL</z:chebi>:<z:chebi fb="15" ids="39026">LDL</z:chebi> and the upper tertile for <z:chebi fb="15" ids="39026">LDL</z:chebi> oxidation; the combined parameters of <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi>, <z:chebi fb="15" ids="39026">LDL</z:chebi> oxidation and scavenging by macrophages show 87% sensitivity towards VaD detection </plain></SENT>
<SENT sid="5" pm="."><plain>The association between <z:chebi fb="3" ids="37445">folate</z:chebi> deficiency, <z:chebi fb="15" ids="39026">LDL</z:chebi> modification and dysfunction in VaD but not in AD may provide a novel biomarker assessment to discriminate between the diseases </plain></SENT>
</text></document>